Trial Profile
A Phase I Study Of PT523 In Patients With Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Dec 2017
Price :
$35
*
At a glance
- Drugs Talotrexin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 20 Dec 2017 New trial record